Company intelligence / Profile preview

M42

Abu Dhabi, Abu Dhabi Emirate, United Arab Emirateslinkedin.com ↗

Ownership: Private
Employees: ~20000
Development stage: Commercial

Overview

M42 delivers global healthcare services across more than 480 facilities in over two dozen countries. It integrates genomics, biobanking, digital health records, population-scale screening programs like the Emirati Genome Programme, and advanced AI-driven approaches to both care delivery and life sciences R&D. The company has recently partnered with Juvenescence to accelerate AI-enabled drug discovery but does not appear to have its own proprietary clinical-stage therapeutics pipeline yet.

Therapeutic areas: OncologyOther
Modalities: Genomics-based diagnostics and solutionsAI-enabled drug discoveryDigital health technologiesBiobanking
Industry: Non-Academic Healthcare

Partnerships

Juvenescence (AI-enabled drug discovery partnership/investment)

Beyond the preview

Go deeper on M42.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on M42.

Explore the full profile